Table of Contents - Espicom
Table of Contents - Espicom
Table of Contents - Espicom
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Table</strong> <strong>of</strong> <strong>Contents</strong><br />
viii<br />
© <strong>Espicom</strong> Business Intelligence © 2012 UBM Semiconductor Insights<br />
Diabetes Landscape:<br />
MD-Logic Artificial Pancreas System ................................................................................................................................................ 173<br />
Medtronic’s Closed-Loop System .......................................................................................................................................................174<br />
Rensselaer Polytechnic Institute .......................................................................................................................................................175<br />
6.0 POC MANUFACTURERS ...........................................................................................................................176<br />
6.1 POC COMPANY DIRECTORY................................................................................................................................................. 176<br />
6.2 LEADING COMPANY PROFILES ........................................................................................................................................... 184<br />
6.2.1 Abbott Laboratories .................................................................................................................................................184<br />
Recent Key Events .......................................................................................................................................................................................................................................184<br />
Blood Glucose Monitors ..................................................................................................................................................................... 185<br />
In Development - Navigator II CGM System .................................................................................................................................... 186<br />
Alliance with Insulet............................................................................................................................................................................. 187<br />
Litigation ............................................................................................................................................................................................... 187<br />
Financial Performance ........................................................................................................................................................................ 188<br />
Abbott Diabetes Care Sales by Region, 2006-2011 (US$ million) ..............................................................................................................................................................188<br />
Fig.6.1: Percentage <strong>of</strong> Abbott Diabetes Care Revenue by Region, 2011 .....................................................................................................................................................188<br />
6.2.2 Arkray .........................................................................................................................................................................189<br />
Recent Key Events ....................................................................................................................................................................................................................................... 189<br />
Blood Glucose Self-Testing ................................................................................................................................................................. 189<br />
Current Alliances and Contracts .........................................................................................................................................................191<br />
6.2.3 Bayer ...........................................................................................................................................................................192<br />
Recent Key Events ....................................................................................................................................................................................................................................... 192<br />
Blood Glucose Monitoring Systems .................................................................................................................................................. 192<br />
Current Alliances .................................................................................................................................................................................. 194<br />
Litigation ................................................................................................................................................................................................ 195<br />
Financial Performance ........................................................................................................................................................................ 195<br />
Bayer Diabetes Care Revenue, 2005-2011 (EUR million) ............................................................................................................................................................................ 195<br />
6.2.4 Becton, Dickinson and Company .............................................................................................................................196<br />
Recent Key Events ....................................................................................................................................................................................................................................... 196<br />
BD Diabetes Care Products ................................................................................................................................................................. 196<br />
Collaboration with the JDRF .............................................................................................................................................................. 197<br />
Litigation with Insulet ......................................................................................................................................................................... 197<br />
Financial Performance ........................................................................................................................................................................ 197<br />
BD Diabetes Care Sales by Region, 2006-2011 (US$ million) ..................................................................................................................................................................... 198<br />
Fig.6.2: Percentage <strong>of</strong> BD Diabetes Care’s Revenue by Region, 2011 ......................................................................................................................................................... 198<br />
6.2.5 DexCom ......................................................................................................................................................................199<br />
Recent Key Events ....................................................................................................................................................................................................................................... 199<br />
SEVEN PLUS CGM System .................................................................................................................................................................... 200<br />
GlucoClear ............................................................................................................................................................................................. 201<br />
Research and Development ............................................................................................................................................................... 201<br />
SweetSpot Diabetes Care Acquisition ............................................................................................................................................. 201<br />
Current Alliances .................................................................................................................................................................................. 202<br />
Litigation with Abbott ........................................................................................................................................................................ 203<br />
Financial Performance ........................................................................................................................................................................ 204<br />
DexCom - Operating Results, 2007-2011 (US$ thousands) ........................................................................................................................................................................205<br />
6.2.6 Insulet ........................................................................................................................................................................ 206<br />
Recent Key Events .......................................................................................................................................................................................................................................207<br />
OmniPod Insulin Management System ........................................................................................................................................... 207<br />
Current Alliances .................................................................................................................................................................................. 208<br />
Acquisition <strong>of</strong> Neighborhood Diabetes ........................................................................................................................................... 209<br />
Litigation with Becton, Dickinson and Company .......................................................................................................................... 209<br />
Financial Performance ........................................................................................................................................................................ 209<br />
Insulet - Operating Results, 2007-2011 (US$ thousands) ........................................................................................................................................................................... 210<br />
6.2.7 Johnson & Johnson ...................................................................................................................................................211<br />
Recent Key Events ....................................................................................................................................................................................................................................... 211<br />
May 2012
Change language